Development and Evaluation of a Rapid Latex Agglutination Test Using a Monoclonal Antibody To Identify Candida dubliniensis Colonies
Open Access
- 1 January 2006
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 44 (1) , 138-142
Abstract
Cell components of the dimorphic pathogenic fungus Candida dubliniensis were used to prepare monoclonal antibodies (MAbs). One MAb, designated 12F7-F2, was shown by indirect immunofluorescence to be specific for a surface antigen of Candida dubliniensis yeast cells. No reactivity was observed with other fungal genera or with other Candida species, including Candida albicans , that share many phenotypic features with C. dubliniensis . The use of different chemical and physical treatments for cell component extraction suggested that the specific epitope probably resides on a protein moiety absent from C. albicans . However, we failed to identify the target protein by Western blotting, owing to its sensitivity to heat and sodium dodecyl sulfate. MAb 12F7-F2 was further used to develop a commercial latex agglutination test to identify C. dubliniensis colonies (Bichro-dubli Fumouze test; Fumouze Diagnostics). The test was validated on yeast strains previously identified by PCR and on fresh clinical isolates; these included 46 C. dubliniensis isolates, 45 C. albicans isolates, and other yeast species. The test had 100% sensitivity and specificity for C. dubliniensis isolated on Sabouraud dextrose, CHROMagar Candida, and CandiSelect media and 97.8% sensitivity for C. dubliniensis grown on Candida ID medium. The test is rapid (5 min) and easy to use and may be recommended for routine use in clinical microbiology laboratories and for epidemiological investigations.Keywords
This publication has 31 references indexed in Scilit:
- Comparative genomics using Candida albicans DNA microarrays reveals absence and divergence of virulence-associated genes in Candida dubliniensisMicrobiology, 2004
- Rapid and simple differentiation of C. dubliniensis from C. albicansDiagnostic Microbiology and Infectious Disease, 2004
- Use of Amplified Fragment Length Polymorphism Analysis To Identify Medically Important Candida spp., Including C . dubliniensisJournal of Clinical Microbiology, 2003
- Differentiation of Candida albicans and Candida dubliniensis by Using Recombinant Human Antibody Single-Chain Variable Fragments Specific for HyphaeJournal of Clinical Microbiology, 2003
- Differentiation of Candida dubliniensis from Candida albicans on Staib Agar and Caffeic Acid-Ferric Citrate AgarJournal of Clinical Microbiology, 2001
- Identification of Candida dubliniensis Based on the Specific Amplification of Mitochondrial Cytochrome b Gene.Nippon Ishinkin Gakkai Zasshi, 2001
- Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequencesMicrobiology, 1999
- Presumptive identification of an emerging yeast pathogen:Candida dubliniensis(sp. nov.) reduces 2,3,5-triphenyltetrazolium chloride: Figure 1FEMS Immunology & Medical Microbiology, 1998
- Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individualsMicrobiology, 1995
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970